These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31688393)

  • 1. Lurasidone-Associated Manic Switch in a Patient With Depression: A Case Report.
    Gupta P; Singh J; Kumar N
    J Clin Psychopharmacol; 2019; 39(6):687-689. PubMed ID: 31688393
    [No Abstract]   [Full Text] [Related]  

  • 2. Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.
    Nair SS; Chua CJM; Teo DCL
    East Asian Arch Psychiatry; 2021 Sep; 31(3):81-83. PubMed ID: 34588318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lurasidone-Induced Mania.
    Ward HB; Almeida M
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31298818
    [No Abstract]   [Full Text] [Related]  

  • 4. Case Series Reports on Lurasidone-Associated Mania.
    Doan LA; Williams SR; Takayesu A; Lu B
    J Clin Psychopharmacol; 2017 Apr; 37(2):264-266. PubMed ID: 28225748
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic Drug Monitoring of Lurasidone in Patients with Schizophrenia or Bipolar Disorder: A preliminary study.
    Huang CY; Lin SK
    Psychiatry Clin Neurosci; 2022 Dec; 76(12):674-675. PubMed ID: 36057778
    [No Abstract]   [Full Text] [Related]  

  • 6. Lurasidone associated neutropenia.
    Singh S; Ahmad H; John AP
    Aust N Z J Psychiatry; 2017 Oct; 51(10):1055. PubMed ID: 28478684
    [No Abstract]   [Full Text] [Related]  

  • 7. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP; Sajatovic M; Tsai J; Pikalov A; Cucchiaro J; Loebel A
    Am J Geriatr Psychiatry; 2018 Feb; 26(2):150-159. PubMed ID: 29146409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year outcomes of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment.
    Wada K; Sasaki T; Jitsuiki H; Takaishi Y
    Int J Psychiatry Clin Pract; 2013 Aug; 17(3):219-22. PubMed ID: 23560620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food Matters: Reduction of Lurasidone-Induced Nausea With Meals.
    Kolli V; Walia A; Kinnan S
    Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30869204
    [No Abstract]   [Full Text] [Related]  

  • 11. Lurasidone: A New Option for Older Adults with Bipolar Disorder?
    Rej S
    Am J Geriatr Psychiatry; 2018 Feb; 26(2):160-161. PubMed ID: 28985992
    [No Abstract]   [Full Text] [Related]  

  • 12. Lurasidone-induced anemia: Is there a need for hematological monitoring?
    Kirpekar VC; Faye AD; Bhave SH; Tadke R; Gawande S
    Indian J Pharmacol; 2019; 51(4):276-278. PubMed ID: 31571715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression.
    Modugula H; Kumar A
    CNS Neurol Disord Drug Targets; 2020; 19(2):109-114. PubMed ID: 32124704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression: A 12-Week Observational Study.
    Takaesu Y; Takeshima M; Watanabe K
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):485-488. PubMed ID: 35916577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study.
    Yatham LN; Mackala S; Basivireddy J; Ahn S; Walji N; Hu C; Lam RW; Torres IJ
    Lancet Psychiatry; 2017 Mar; 4(3):208-217. PubMed ID: 28185899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lurasidone-Induced Rabbit Syndrome: A Case Report.
    Reichenberg JL; Ridout KK; Rickler KC
    J Clin Psychiatry; 2017 May; 78(5):e553. PubMed ID: 28570801
    [No Abstract]   [Full Text] [Related]  

  • 17. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
    Calabrese JR; Pikalov A; Streicher C; Cucchiaro J; Mao Y; Loebel A
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Lurasidone-Induced Polydipsia Complicated by Hyponatremia in a Patient With Bipolar Disorder.
    Li ST; Yeh YW
    Clin Neuropharmacol; 2021 Nov-Dec 01; 44(6):243-244. PubMed ID: 34561339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of treatments for bipolar depression.
    Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
    J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
    Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
    World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.